Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04208971 · ClinicalTrials.gov registry record
Batch Enrollment for AI-Guided Intervention to Lower Neurologic Events in Unrecognized AF
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 1,225
- Enrollment target
NCT04208971: Completed study, sponsored by Mayo Clinic.
NCT04208971 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 1,225 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04208971 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 1,225 participants
- Enrollment target
Study Summary
This is a prospective study to test a novel artificial intelligence (AI)-enabled electrocardiogram (ECG)-based screening tool for improving the diagnosis of unrecognized atrial fibrillation (AF) and stroke prevention.
Interventions
- OTHER AI-enabled ECG-based Screening Tool for AF
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,225 participants |
| Start Date | 2020-11-02 |
| Est. Completion | 2022-01-27 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04208971
The ClinicalTrials.gov registry entry for NCT04208971 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,225 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which AI-enabled ECG-based Screening Tool for AF is the first listed.
NCT04208971 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04208971 about?
NCT04208971 is a clinical study titled "Batch Enrollment for AI-Guided Intervention to Lower Neurologic Events in Unrecognized AF". This is a prospective study to test a novel artificial intelligence (AI)-enabled electrocardiogram (ECG)-based screening tool for improving the diagnosis of unrecognized atrial fibrillation (AF) and stroke prevention.
What is the current status of trial NCT04208971?
This trial is currently completed. The enrollment target is 1,225 participants. The study started on 2020-11-02. Estimated completion is 2022-01-27.
What interventions are being tested in trial NCT04208971?
The interventions under investigation include: AI-enabled ECG-based Screening Tool for AF (OTHER).
Who is sponsoring clinical trial NCT04208971?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.